Epigenetic Data Sciences

About The Team


Loretta Anderson, Director of Research


Loretta Anderson has served as Director of Research since May 2017. She is a well-respected expert in her field, and is recognized globally for her work in aging and Alzheimer’s disease. Additionally, she has worked on research related to autism spectrum disorders, chronic kidney disease, and insomnia. Currently, Loretta oversees the cancer research division at Epigenetic Data Sciences, and she will be instrumental in expanding our research divisions in neuroscience and chronic diseases. She earned her M.H.S. from Johns Hopkins Bloomberg School of Public Health and her M.A. in Applied Economics from Johns Hopkins Advanced Academic Programs. She earned her B.A. in Business at the College of Notre Dame of Maryland. Loretta offers great depth and breadth of knowledge across a variety of healthcare specialties. With her leadership, she will offer our team the direction needed to develop the latest research protocols for those wishing to prevent or fight disease. She is an avid volunteer in her community and enjoys supporting causes related to a variety of healthcare issues, children’s services, and higher education.



Rebecca Pollack, Project Manager


Rebecca Pollack has served as Project Manager since January 2017. She is the project leader for the BCan360 breast cancer protocol. She has several years of experience in clinical sciences, with a focus on disease prevention. Before coming to EDS, she coordinated a national project to increase access to flu vaccines across all levels of socioeconomic status. Rebecca earned her B.A. in Psychology from the University of South Carolina. In her spare time, she is an avid volunteer for both the American Cancer Society and the Alzheimer’s Association. As a Project Manager at Epigenetic Data Sciences, Rebecca works in tandem with her father, Andrew, to expand the company’s research, marketing, and development interests. Her extensive project management experience, rigorous education, and passion to fight cancer add a level of detail and depth to the management of all current and future Epigenetic Data Sciences projects.